Bridgeway Capital Management’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-223,500
| Closed | -$44K | – | 1431 |
|
|
2019
Q1 | $44K | Hold |
223,500
| – | – | ﹤0.01% | 1316 |
|
|
2018
Q4 | $156K | Hold |
223,500
| – | – | ﹤0.01% | 1252 |
|
|
2018
Q3 | $275K | Buy |
+223,500
| New | +$275K | ﹤0.01% | 1267 |
|
|
2017
Q2 | – | Sell |
-187,500
| Closed | -$349K | – | 1498 |
|
|
2017
Q1 | $349K | Hold |
187,500
| – | – | ﹤0.01% | 1171 |
|
|
2016
Q4 | $971K | Hold |
187,500
| – | – | 0.01% | 833 |
|
|
2016
Q3 | $1.04M | Buy |
187,500
+30,000
| +19% | +$167K | 0.02% | 776 |
|
|
2016
Q2 | $874K | Buy |
157,500
+38,500
| +32% | +$214K | 0.01% | 829 |
|
|
2016
Q1 | $524K | Hold |
119,000
| – | – | 0.01% | 1027 |
|
|
2015
Q4 | $716K | Hold |
119,000
| – | – | 0.01% | 908 |
|
|
2015
Q3 | $931K | Hold |
119,000
| – | – | 0.02% | 774 |
|
|
2015
Q2 | $729K | Buy |
119,000
+40,000
| +51% | +$245K | 0.01% | 906 |
|
|
2015
Q1 | $636K | Buy |
79,000
+8,614
| +12% | +$69.3K | 0.01% | 988 |
|
|
2014
Q4 | $356K | Sell |
70,386
-9,614
| -12% | -$48.6K | 0.01% | 1176 |
|
|
2014
Q3 | $415K | Hold |
80,000
| – | – | 0.01% | 1168 |
|
|
2014
Q2 | $622K | Hold |
80,000
| – | – | 0.02% | 985 |
|
|
2014
Q1 | $558K | Buy |
80,000
+40,000
| +100% | +$279K | 0.02% | 1022 |
|
|
2013
Q4 | $240K | Sell |
40,000
-29,400
| -42% | -$176K | 0.01% | 1263 |
|
|
2013
Q3 | $541K | Buy |
69,400
+15,000
| +28% | +$117K | 0.02% | 997 |
|
|
2013
Q2 | $207K | Buy |
+54,400
| New | +$207K | 0.01% | 1264 |
|